Factor V Leiden: Difference between revisions
Farmersj333 (talk | contribs) |
Elcatracho (talk | contribs) |
||
| Line 32: | Line 32: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[Category:Hematology and Oncology] | |||
Revision as of 05:01, 25 January 2021
Background
- Also known as Factor V Leiden Deficiency or FVL
- Point mutation in FV making it resistant to cleavage by activated protein C
- Increased risk of thrombosis
- Most individuals with FVL will never have a venous thromboembolism (VTE)
Clinical Features
- Family history of thrombophilia
- VTE at a young age
- VTE in an atypical location
Differential Diagnosis
Evaluation
Workup
Diagnosis
Management
Disposition
See Also
External Links
References
[Category:Hematology and Oncology]
